CNX Resources Corp (CNX) earnings date, results and what the price requires
NYSE · SEC CIK 0001070412 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | $618.5M | $202.9M | $1.32 | Filing |
| Mar 31, 2026 | Apr 30, 2026 | $786.7M | $348.1M | $2.18 | Filing |
| Dec 31, 2025 | Jan 29, 2026 | $610.5M | $196.3M | $1.58 | Filing |
| Sep 30, 2025 | Oct 30, 2025 | $583.8M | $202.1M | $1.21 | Filing |
| Jun 30, 2025 | Jul 24, 2025 | $962.4M | $432.5M | $2.53 | Filing |
| Mar 31, 2025 | Apr 24, 2025 | $82.4M | $-197.7M | $-1.34 | Filing |
| Dec 31, 2024 | Jan 30, 2025 | $136.6M | $-144.6M | $-0.89 | Filing |
| Sep 30, 2024 | Oct 24, 2024 | $424.2M | $65.5M | $0.37 | Filing |
What would CNX Resources Corp have to report for its valuation to change?
At $35.91, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -13.4% a year, to $3.07. On that path the next quarter needs diluted EPS near $1.05, against $1.21 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | -13.4% | -13.4% |
| EPS needed in final year | $3.07 | $3.07 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. CNX goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.